Active, not recruitingPhase 3NCT04065009

The IPLA-OVCA Trial, Intra-Peritoneal Local Anaesthetics in Ovarian Cancer

Studying Malignant epithelial tumor of ovary

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Karolinska Institutet
Principal Investigator
Sahar Salehi, MD, PhD
Karolinska Institute and Karolinska University Hospital
Intervention
Ropivacaine(drug)
Enrollment
220 enrolled
Eligibility
18-80 years · FEMALE
Timeline
20202028

Study locations (1)

Collaborators

Skane University Hospital

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04065009 on ClinicalTrials.gov

Other trials for Malignant epithelial tumor of ovary

Additional recruiting or active studies for the same condition.

See all trials for Malignant epithelial tumor of ovary

← Back to all trials